Comprehensive Overview of Toxoplasma gondii-Induced and Associated Diseases
- PMID: 34832507
- PMCID: PMC8625914
- DOI: 10.3390/pathogens10111351
Comprehensive Overview of Toxoplasma gondii-Induced and Associated Diseases
Abstract
Toxoplasma gondii (T. gondii) is a prevalent protozoan parasite of medical and veterinary significance. It is the etiologic agent of toxoplasmosis, a neglected disease in which incidence and symptoms differ between patients and regions. In immunocompetent patients, toxoplasmosis manifests as acute and chronic forms. Acute toxoplasmosis presents as mild or asymptomatic disease that evolves, under the host immune response, into a persistent chronic disease in healthy individuals. Chronic toxoplasmosis establishes as latent tissue cysts in the brain and skeletal muscles. In immunocompromised patients, chronic toxoplasmosis may reactivate, leading to a potentially life-threatening condition. Recently, the association between toxoplasmosis and various diseases has been shown. These span primary neuropathies, behavioral and psychiatric disorders, and different types of cancer. Currently, a direct pre-clinical or clinical molecular connotation between toxoplasmosis and most of its associated diseases remains poorly understood. In this review, we provide a comprehensive overview on Toxoplasma-induced and associated diseases with a focus on available knowledge of the molecular players dictating these associations. We will also abridge the existing therapeutic options of toxoplasmosis and highlight the current gaps to explore the implications of toxoplasmosis on its associated diseases to advance treatment modalities.
Keywords: behavioral disorders; neurological disorders; neuropathies; psychiatric disorders; toxoplasmosis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Imiquimod Reverses Chronic Toxoplasmosis-Associated Behavioral and Neurocognitive Anomalies in a Rat Model.Biomedicines. 2024 Jun 11;12(6):1295. doi: 10.3390/biomedicines12061295. Biomedicines. 2024. PMID: 38927503 Free PMC article.
-
Toxoplasmosis: Current and Emerging Parasite Druggable Targets.Microorganisms. 2021 Dec 7;9(12):2531. doi: 10.3390/microorganisms9122531. Microorganisms. 2021. PMID: 34946133 Free PMC article. Review.
-
[Toxoplasma gondii: a potential role in the genesis of psychiatric disorders].Encephale. 2013 Feb;39(1):38-43. doi: 10.1016/j.encep.2012.06.014. Epub 2012 Aug 21. Encephale. 2013. PMID: 23095600 Review. French.
-
Impact of Engineered Expression of Mitochondrial Association Factor 1b on Toxoplasma gondii Infection and the Host Response in a Mouse Model.mSphere. 2018 Oct 17;3(5):e00471-18. doi: 10.1128/mSphere.00471-18. mSphere. 2018. PMID: 30333181 Free PMC article.
-
Human toxoplasmosis in Mozambique: gaps in knowledge and research opportunities.Parasit Vectors. 2020 Nov 11;13(1):571. doi: 10.1186/s13071-020-04441-3. Parasit Vectors. 2020. PMID: 33176884 Free PMC article. Review.
Cited by
-
Clinical and imaging characteristics of toxoplasmic encephalitis in patients with HIV/AIDS with different immune statuses.Quant Imaging Med Surg. 2025 Aug 1;15(8):7259-7268. doi: 10.21037/qims-2024-2598. Epub 2025 Jul 17. Quant Imaging Med Surg. 2025. PMID: 40785890 Free PMC article.
-
Imiquimod Reverses Chronic Toxoplasmosis-Associated Behavioral and Neurocognitive Anomalies in a Rat Model.Biomedicines. 2024 Jun 11;12(6):1295. doi: 10.3390/biomedicines12061295. Biomedicines. 2024. PMID: 38927503 Free PMC article.
-
Transcriptomic and metabolomic analyses reveal the essential nature of Rab1B in Toxoplasma gondii.Parasit Vectors. 2023 Nov 8;16(1):409. doi: 10.1186/s13071-023-06030-6. Parasit Vectors. 2023. PMID: 37941035 Free PMC article.
-
Single and combination treatment of Toxoplasma gondii infections with a bumped kinase inhibitor and artemisone in vitro and with artemiside in experimentally infected mice.Exp Parasitol. 2023 Dec;255:108655. doi: 10.1016/j.exppara.2023.108655. Epub 2023 Nov 18. Exp Parasitol. 2023. PMID: 37981259 Free PMC article.
-
Immune dynamics throughout life in relation to sex hormones and perspectives gained from gender-affirming hormone therapy.Front Immunol. 2025 Jan 16;15:1501364. doi: 10.3389/fimmu.2024.1501364. eCollection 2024. Front Immunol. 2025. PMID: 39885993 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources